OPKO Health, Inc. Related Party Transaction, Expenses from Transactions with Related Party
OPKO Health, Inc. (OPK) reported Related Party Transaction, Expenses from Transactions with Related Party of $0 for the 3-month period ending 2022-09-30, per its 10-Q filed 2022-11-08.
Discontinued › Expense Statement › Operating Expenses
us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty · last filed 2022-11-08
- OPKO Health, Inc. related party transaction, expenses from transactions with related party for the quarter ending 2022-09-30 was $0.00.
- OPKO Health, Inc. related party transaction, expenses from transactions with related party for the quarter ending 2022-06-30 was $0.00.
- OPKO Health, Inc. related party transaction, expenses from transactions with related party for the quarter ending 2022-03-31 was $31.00K.
- OPKO Health, Inc. related party transaction, expenses from transactions with related party for the quarter ending 2021-09-30 was $0.00, a 100.00% decline year-over-year.
| Period end | Related Party Transaction, Expenses from Transactions with Related Party 3 month | Related Party Transaction, Expenses from Transactions with Related Party 3 month as first filed | Related Party Transaction, Expenses from Transactions with Related Party 6 month | Related Party Transaction, Expenses from Transactions with Related Party 9 month |
|---|---|---|---|---|
| 2022-09-30 | $0.00 10-Q · filed 2022-11-08 | $0.00 derived: sum of 2 quarters · filed 2022-11-08 | $31.00K 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $0.00 10-Q · filed 2022-08-04 | $30.00K 10-Q · filed 2022-08-04 | ||
| 2022-03-31 | $31.00K 10-Q · filed 2022-05-09 | |||
| 2021-09-30 | $0.00 10-Q · filed 2022-11-08 | $0.00 derived: sum of 2 quarters · filed 2022-11-08 | $43.00K 10-Q · filed 2022-11-08 | |
| 2021-06-30 | $0.00 10-Q · filed 2022-08-04 | $43.00K 10-Q · filed 2021-07-29 | $43.00K 10-Q · filed 2022-08-04 | |
| 2021-03-31 | $0.00 10-Q · filed 2022-05-09 | |||
| 2020-09-30 | $62.00K 10-Q · filed 2021-10-28 | $62.00K derived: sum of 2 quarters · filed 2021-10-28 | $156.00K 10-Q · filed 2021-10-28 | |
| 2020-06-30 | $0.00 10-Q · filed 2021-07-29 | $94.00K 10-Q · filed 2021-07-29 | ||
| 2020-03-31 | $94.00K 10-Q · filed 2021-04-28 | |||
| 2019-09-30 | $0.00 10-Q · filed 2020-10-29 | $122.00K derived: sum of 2 quarters · filed 2020-10-29 | $160.00K 10-Q · filed 2020-10-29 | |
| 2019-06-30 | $122.00K 10-Q · filed 2020-07-31 | $160.00K 10-Q · filed 2020-07-31 | ||
| 2019-03-31 | $37.00K 10-Q · filed 2020-05-06 | |||
| 2018-09-30 | $34.00K 10-Q · filed 2019-11-05 | $95.00K derived: sum of 2 quarters · filed 2019-11-05 | $174.00K 10-Q · filed 2019-11-05 | |
| 2018-06-30 | $61.00K 10-Q · filed 2019-08-07 | $140.00K 10-Q · filed 2019-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |